Countries Australia
MSD and Moderna Launch Phase 3 Study for Melanoma Treatment
“As we continue our efforts to advance novel treatment options for patients with high-risk Stage IIB-IV melanoma, the initiation of the V940-001 Phas...
July 28, 2023 | News
Hummingbird Bioscience Advances HMBD-001 Phase IB Trials in Australia, Partners with Omico for Faster Clinical Development
Hummingbird Bioscience has initiated two clinical trials in Australia evaluating HMBD-001 in patients with squamous non-small cell lung ca...
July 27, 2023 | News
HaemaLogiX, Peter MacCallum Cancer Centre Announce Myeloma CAR-T Trial Agreement
HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's ...
July 26, 2023 | News
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
SABRE (Copper-64 SAR-Bombesin in Biochemical Recurrence of prostate cancer) is a Phase II Positron Emission Tomography (PET) imaging tr...
July 25, 2023 | News
RenovoRx and Imugene Join Forces for Oncolytic Virus Therapy Using TAMP Platform
Collaboration will explore trans-arterial delivery of Imugene's CF33 oncolytic virus utilizing RenovoRx's TAMP therapy platform TAMP enables localized, ...
July 25, 2023 | News
ConcertAI's TeraRecon Expands Relationship with Change Healthcare for Advanced Visualization in Australia
Advanced visualization and AI leader TeraRecon, a ConcertAI company, is excited to announce an expansion of its reseller and service agreement in Aust...
July 24, 2023 | News
Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow
Summary Total revenue up 21% quarter-on-quarter to $120.7M driven by global product sales Positive operating cash flow ($10.8M, an improvemen...
July 20, 2023 | News
Merck and Telix Continue Collaboration for Targeted Radiation Therapy Studies.
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Com...
July 19, 2023 | News
Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination
- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...
July 18, 2023 | News
Antengene's XPOVIO® Approved in Hong Kong for Relapsed Multiple Myeloma
XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...
July 17, 2023 | News
Brii Biosciences Expands Hepatitis B Leadership with Comprehensive Portfolio from Prevention to Cure
Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from VBI in Greater China ...
July 06, 2023 | News
FDA Approves Cu-64 SAR-bisPSMA Phase III Trial for Prostate Cancer
FDA agreement for a pivotal Phase III trial for 64Cu SAR-bisPSMA diagnostic in prostate cancer Phase III trial design based on&n...
July 05, 2023 | News
Lumos Receives US FDA Clearance for FebriDx®
The clearance allows FebriDx to be marketed in the US for use by healthcare professionals as an aid in the diagnosis of bacterial acute respiratory infecti...
July 04, 2023 | Regulatory
Lymphoma Therapy Approved for Australian Patients with Diffuse Large B-cell Lymphoma
MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-year follow-up data from Phase 2 L-MIND investig...
June 28, 2023 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
- Eva van Pelt Joins Qiagen's Supervisory Board, Bringing a Wealth of Global Leadership Experience in Healthcare and Life Sciences
- Life Sciences Queensland Welcomes Dr. Kym Baker and Dr. Denise Hodge to Board Leadership
- Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility
- Veranova Appoints Mike Riley as Chief Executive Officer
- Find your Job at Eppendorf
News
Editor Picks
